Loading
Biomerica Inc Stock: price and insider trades · United States
5 insiders bought €135k of shares over the last 90 days, the latest by BARBIERI ALLEN, filed 27 Aug 2026.
Insider Decl.
150
Thresholds
n/a
Buy Volume
€387,552
83 ops. · all time
Sell Volume
€243,654
16 ops. · all time
Who traded when
BuySaleAllen Barbieri1 buy
David Moatazedi1 buy
Eric Chin1 buy
M. Huff Gary1 buy
Zackary S. Irani1 buy
Since the insiders bought
- -20.0%Entry US$2.14 · Close 21 Oct 2026 US$1.71
- -20.0%Entry US$2.14 · Close 21 Oct 2026 US$1.71
- -20.0%Entry US$2.14 · Close 21 Oct 2026 US$1.71
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 26,183 of 26,280 companies
4.3
score / 100
Value5
Quality4
FCF yld-44%
Earn yld-48%
EV/EBITDA·
ROE-114%
Gross mgn8.1%
Net mgn-85%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended May 2026 · cache
US$1.71
Analyst consensus
Income statement
RevenueUS$4.5M
Gross profitUS$362k8% margin
EBITDA-US$4.9M-110% margin
Net income-US$3.8M-115.5% margin
Valuation
P/Book2.2x
Beta0.38
Balance sheet & cash
Market capUS$7.9M
Total debtUS$2.4M
Free Cash Flow-US$3.4M
Debt / Equity64%
Profitability & ownership
ROE-113.8%
ROA-45.5%
% insiders21.9%
% institutions2.7%
Last declaration on 27 August 2026
Declarations150 total
20,000 shares@ US$1.600.26% mcap42.8% of flowCommon stockSEC:0001493152-26-040444:0
Canonical exit: 24 Nov 2026 (T+90)
31,250 shares@ US$1.600.41% mcap30.0% of flowCommon stockSEC:0001493152-26-040443:0
Canonical exit: 24 Nov 2026 (T+90)
6,250 shares@ US$1.600.082% mcap100.0% of flowCommon stockSEC:0001493152-26-040448:0
Canonical exit: 24 Nov 2026 (T+90)
10,000 shares@ US$1.600.13% mcap35.3% of flowCommon stockSEC:0001493152-26-040450:0
Canonical exit: 24 Nov 2026 (T+90)
31,250 shares@ US$1.600.41% mcap100.0% of flowCommon stockSEC:0001493152-26-040454:0
Canonical exit: 18 Nov 2026 (T+90)
22,500 shares0Common stockSEC:0001493152-26-004083:0
40,000 shares0Common stockSEC:0001493152-25-029843:0
52,500 shares0Common stockSEC:0001493152-25-029842:0
30,000 shares0Common stockSEC:0001493152-25-029841:0
20,000 shares0Common stockSEC:0001493152-25-029840:0
20,000 shares0Common stockSEC:0001493152-25-029839:0
250,000 shares@ US$0.3151.9% of flowCommon stockSEC:0001493152-24-050501:0
155,000 shares@ US$0.31100.0% of flowCommon stockSEC:0001493152-24-050503:0
85,000 shares@ US$0.31100.0% of flowCommon stockSEC:0001493152-24-050502:0
85,000 shares@ US$0.3180.9% of flowCommon stockSEC:0001493152-24-050500:0
110,000 shares@ US$0.3150.8% of flowCommon stockSEC:0001493152-24-050499:0
85,000 shares@ US$0.3164.7% of flowCommon stockSEC:0001493152-24-050504:0
200 shares@ US$1.550.0% of flowCommon StockSEC:0001513162-23-000101:1
Canonical exit: 23 Aug 2023 (T+90)
500 shares@ US$1.610.5% of flowCommon StockSEC:0001513162-23-000101:0
Canonical exit: 22 Aug 2023 (T+90)
1,700 shares@ US$1.171.3% of flowCommon StockSEC:0001513162-23-000092:0
Canonical exit: 10 Aug 2023 (T+90)
500 shares@ US$1.270.4% of flowCommon StockSEC:0001513162-23-000091:0
Canonical exit: 8 Aug 2023 (T+90)
300 shares@ US$1.390.3% of flowCommon StockSEC:0001513162-23-000088:0
Canonical exit: 7 Aug 2023 (T+90)
1,000 shares@ US$1.360.9% of flowCommon StockSEC:0001513162-23-000082:0
Canonical exit: 2 Aug 2023 (T+90)
1,800 shares@ US$1.340.4% of flowCommon StockSEC:0001513162-23-000078:1
Canonical exit: 27 Jul 2023 (T+90)
2,600 shares@ US$1.312.2% of flowCommon StockSEC:0001513162-23-000078:0
Canonical exit: 26 Jul 2023 (T+90)
25 of 150 declarations
About Biomerica Inc
Biomerica Inc concentrates 75 of its 150 filings in 2016, and above all the cluster of August 1 to 12, 2016, when 6 insiders bought for EUR 118,957; 67 purchase filings fall in 30-day windows. In all, 84 purchases are worth EUR 393,438 (median EUR 1,832) against 16 sales worth EUR 243,654 (median EUR 13,969): 84% of open-market trades are purchases. Zackary S. Irani, Chief Executive Officer, signs 59 filings including 46 purchases, with the largest on file, EUR 42,830 on August 26, 2026, ahead of M. Huff Gary, Director, with EUR 42,795 on August 20, 2026, and Catherine Coste, Director, with EUR 41,858 on October 26, 2020. The largest sales are Mark A. Sirgo's, Director, EUR 37,351 on April 21, 2020, and Francis E. Capitanio's, President, EUR 34,900 on February 27, 2017 and EUR 26,511 on May 16, 2016. The 13 filers publish between March 29, 2016 and August 27, 2026, a median of 1 day after the trade. In the last twelve months, 11 filings include 5 purchases and no sale. The US health care company is worth USD 8.1 million, with 21.9% held by insiders. For 77 purchases the stored 90-day result has a median of -24.3%, with 27% of results positive: recorded past results, not a forecast.
